Oncopeptides AB (publ) announced that the company has appointed Henrik Bergentoft as Chief Financial Officer, CFO. Henrik was most recently CFO at RaySearch Laboratories and brings 20+ years of experience from leading finance roles at both medical and non-medical, publicly listed organizations. He will assume his new position during the fourth quarter, replacing Holger Lembrér.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.705 SEK | +0.37% | -2.70% | -64.69% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.69% | 55.73M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- ONCO Stock
- News Oncopeptides AB
- Oncopeptides AB Appoints Henrik Bergentoft as Chief Financial Officer